Skip to content

‘The effect of hypnotherapy on asthma control in children.’

‘The effect of hypnotherapy on asthma control in children.’

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21081
Enrollment
60
Registered
2017-03-27
Start date
2017-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma exercise induced bronchoconstriction

Interventions

Hypnotherapie

Sponsors

Stichting Pediatrisch Onderzoek Enschede
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age between 8-18 years - Paediatrician diagnosed asthma with mild to moderate EIB (13%-40% fall in FEV1) as measured with an ECT - Ability to perform spirometry and ECT’s and to receive hypnotherapy training

Exclusion criteria

Exclusion criteria: - Other pulmonary or cardiac illnesses - Severe EIB i.e. a fall of ≥40% FEV1 in the first ECT, requiring an acute change in maintenance medication (standard care) - Other symptoms of uncontrolled asthma such as nocturnal asthmatic symptoms, exacerbations in the 4 preceding weeks and during the study. - Use of long acting bronchodilator agents 24 hours before testing - Use of short acting bronchodilator agents 8 hours before testing - Hospitalization or systemic prednisolone due to asthma exacerbation in last 6 weeks - Other changes in asthma medication during treatment period - Upper or lower respiratory tract infections during treatment period

Design outcomes

Primary

MeasureTime frame
•To assess the protective effect of hypnotherapy training on asthma control (measured with the fall in FEV1 after an ECT) in asthmatic children with EIB between 8-18 years.

Secondary

MeasureTime frame
• To assess the protective effect of hypnotherapy on EIB as assessed with Forced Oscillation Therapy (FOT). • To assess the effect of hypnotherapy training on subjective asthmatic symptoms in asthmatic children between 8-18 years, using the C-ACT and the PAQLQ.

Contacts

Public ContactN. Lammers

Afdeling kindergeneeskunde

n.lammers@mst.nl053 4872310

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)